Die Suchmaschine für Unternehmensdaten in Europa
EU-Förderung (5.998.456 €): Gemeinsame Infrastruktur für nationale Kohorten in Europa, Kanada und Afrika Hor 01.01.2019 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Gemeinsame Infrastruktur für nationale Kohorten in Europa, Kanada und Afrika
Thousands of human genomes and other biomolecular datasets are now being generated in health, rather than research contexts. Centralised storage and analysis of these is no longer technically feasible for data harmonisation, curation, sharing or analysis and ethical, legal, social reasons. CINECA’s vision is a federated cloud enabled infrastructure making population scale genomic and biomolecular data accessible across international borders, accelerating research, and improving the health of individuals across continents. CINECA will leverage international investment in human cohort studies from Europe, Canada, and Africa to deliver a paradigm shift of federated research and clinical applications. The CINECA consortium will create one of the largest cross-continental implementations of human genetic and phenotypic data federation and interoperability with a focus on common (complex) disease, one of the world’s most significant health burdens. The partners represent a unique combination of scientific excellence with experience of eleven diverse cohorts and scientific projects such as the European Genome-phenome Archive, CanDIG, and H3Africa. CINECA has assembled a virtual cohort of 1.4M individuals from population, longitudinal and disease studies. Federated analyses will deliver new scientific knowledge, harmonisation strategies and the necessary ELSI framework supporting data exchange across legal jurisdictions enabling federated analyses in the cloud. CINECA will provide a template to achieve virtual longitudinal and disease specific cohorts of millions of samples, to advance benefits to patients. CINECA will leverage partner membership of standards and infrastructures like the Global Alliance for Global Health, BBMRI, ELIXIR, and EOSC driving the state of the art in standards development, technical implementation and FAIR data.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Academisch Ziekenhuis Groningen | 576.375 € |
| Biobanks AND Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric) | 350.099 € |
| Clinicageno Ltd. | 228.375 € |
| CSC-Tieteen Tietotekniikan Keskus Oy | 491.455 € |
| Erasmus Universitair Medisch Centrum Rotterdam | 464.110 € |
| European Molecular Biology Laboratory | 1.548.809 € |
| Fundacio Centre de Regulacio Genomica | 185.750 € |
| Haute Ecole Specialisee DE Suisse Occidentale | 647.500 € |
| Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit UND Umwelt GmbH | 218.992 € |
| Institut National de la Sante et de la Recherche Medicale | 152.918 € |
| Masarykova Univerzita | 163.000 € |
| Royal Institution FOR THE Advancement OF Learning Mcgill University | 0,00 € |
| SIB Swiss Institute OF Bioinformatics | 279.250 € |
| Simon Fraser University | 0,00 € |
| Tartu Ulikool | 206.250 € |
| The Chancellor, Masters and Scholars of the University of Oxford | 1.058,39 € |
| The Hospital for Sick Children | 0,00 € |
| THE Hyve B.V. | 211.618 € |
| University OF Cape Town | 272.899 € |
Quelle: https://cordis.europa.eu/project/id/825775
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.